CeQur Simplicity key facts
as of Oct 2026- Developer of an insulin patch designed to simplify insulin delivery and improve the lives of diabetes patients.
- CeQur Simplicity is valued at approximately $342.4M as of Oct 2026 (last reported valuation).
- It has raised $392.9M; the latest was Later Stage VC ($120.0M) in Jan 2025.
- Notable investors include Vi Partners, Schroders, Woodford Investment Management, Kingdon Capital Management, Endeavour Vision — 9 tracked in total.
- Status: Privately Held (backing).
CeQur Simplicity's last reported valuation, Sep 2015. Nothing priced has surfaced since.
- ·Watch CeQur Simplicity: the Monday email on marks, rounds and moves
CeQur Simplicity funding rounds
No funding rounds for CeQur Simplicity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CeQur Simplicity valuation
CeQur Simplicity's last reported valuation was $342 million in Sep 2015. No priced round, secondary trade or fund mark has surfaced since.
CeQur Simplicity investors
9 investors are on record for CeQur Simplicity, including Vi Partners, Schroders, Woodford Investment Management and Kingdon Capital Management.
About CeQur Simplicity
Developer of an insulin patch designed to simplify insulin delivery and improve the lives of diabetes patients. The company's device consists of a simple and discreet wearable insulin delivery holder that delivers both basal and bolus insulin, enabling patients to easily experience the benefits of intensive insulin therapy while remaining free from the burdens of daily insulin injections.
- Sector
- Healthcare
- HQ
- Luzern, Switzerland
- Founded
- 2008
- Employees
- 135
- Website
- myceqursimplicity.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.